scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that, through our proprietary platform, are designed to enable the subcutaneous administration of therapies previously limited to intravenous (IV) delivery—with the goal of transforming infused therapies, advancing patient care, and reducing healthcare costs.

Biotechnology

Pharmaceutical

scPharmaceuticals

John H. Tucker

Tara Hendrzak

Monica Mazziotti

Michelle Whipple

Lucy Johnston

Katie Luepke, PharmD, BCPS, CMPP

Jennifer Vandiver

Jeff Mastrangelo

Eric Kendig

Carolyn Scimemi

Anthony DeFilippo, MBA, RPh

Rachael Nokes

John Mohr

Mike Hassman

The executive team at scPharmaceuticals have experience in a variety of pharmaceutical companies, including Alcresta, AMAG Pharmaceuticals, and Incline Therapeutics, Inc. They have also held positions such as CEO, VP, and Chief Commercial Officer. The team is also educated, with degrees from Southern New Hampshire University in Business.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at scPharmaceuticals

Board of Directors

Leadership Team